SEC Form 4 · accession 0000899243-16-035127

Editas Medicine, Inc. · EDIT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Dec 7, 2016

Accepted (ET)

Dec 8, 2016 · 5:07 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001650664

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Dec 7, 2016	S	75,000	$15.82	D	3,797,144	I	See Footnote

No Table II lines on this filing.

F1Represents 70,859 shares disposed of by Polaris Venture Partners VI, L.P. ("PVP VI") and 4,141 shares disposed of by Polaris Venture Partners Founders' Fund VI, L.P ("PVPFF VI").
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.70 to $15.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F33,587,503 of these shares are owned directly by PVP VI and 209,641 of the shares are owned by PVPFF VI (together with PVP VI, the "Polaris Funds"). Polaris Venture Management Co. VI, L.L.C. ("Polaris Management") is the general partner of each of the Polaris Funds. Kevin Bitterman, a member of the Board of Directors of the Issuer, has an assignee interest in Polaris Management. Each of Polaris Management and Mr. Bitterman disclaim beneficial ownership of all the shares owned by the Polaris Funds and this report shall not be deemed an admission that either is the beneficial owner of such shares for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interests therein.